Alembic Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Alembic Pharma	Jubilant Pharmova	Natco Pharma
Operational Metrics
Pharmaceuticals
US DMF Filings	149.0 .	98.0 .	58.0 .
Number of ANDA's Filed in Europe	21.0	38.0	n/a
Number of ANDA's Approved in Europe	19.0	37.0	n/a
Number of ANDA's Filed in Canada	21.0	24.0	n/a
Number of ANDA's Approved by Canada	20.0	24.0	n/a
Number of ANDA's Filed in Australia	17.0	n/a	n/a
Number of ANDA's Approved by Australia	14.0	n/a	n/a
Number of ANDA's Filed in South Africa	21.0	n/a	n/a
Number of ANDA's Approved by South Africa	7.0	n/a	n/a
Number of ANDA's Filed in Latam	14.0	n/a	n/a
Number of ANDA's Approved by Latam	4.0	n/a	n/a
Number of ANDA's Filed in USA	274.0 .	100.0 .	51.0 .
Number of ANDA's Approved By USFDA	235.0 .	62.0 .	41.0 .
R&D as a % of Total Sales	11.0 %	0.18 %	9.1 %
Financials
5 yr Average ROE	10.74 %	8.05 %	15.58 %
5yr average Equity Multiplier	1.42	1.96	1.17
5yr Average Asset Turnover Ratio	0.87	0.61	0.48
5yr Avg Net Profit Margin	8.74 %	6.45 %	26.79 %
Price to Book	2.94	2.19	1.89
P/E	24.76	38.93	12.27
5yr Avg Cash Conversion Cycle	-59.57 Days	-39.98 Days	4.27 Days
Inventory Days	82.48 Days	74.06 Days	91.91 Days
Days Receivable	36.7 Days	45.59 Days	93.3 Days
Days Payable	158.86 Days	149.89 Days	134.54 Days
5yr Average Interest Coverage Ratio	14.99	3.78	60.49
5yr Avg ROCE	13.06 %	8.15 %	19.09 %
5yr Avg Operating Profit Margin	14.85 %	16.76 %	34.0 %
5 yr average Debt to Equity	0.17	0.55	0.06
5yr CAGR Net Profit	5.31 %	0.08 %	33.73 %
5yr Average Return on Assets	7.6 %	4.12 %	13.46 %
Shareholdings
Promoter Holding	69.74 %	47.68 %	49.42 %
Share Pledged by Promoters	0.0	5.4 %	0.0
Change in Promoter Holding (3 Yrs)	0.13 %	-3.0 %	-0.34 %
Change in Mutual Fund Holding (3 Yrs)	1.71 %	7.63 %	-7.53 %

Business

	Alembic Pharma	Jubilant Pharmova	Natco Pharma
Product Wise Break-Up	Product Wise Break-Up Formulations 81.22 Active Pharmaceutical Ingredient (API) 18.78 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Crop Health 0 API(Domestic & Exports) 0 Formulation 0	Product Wise Break-Up Crop Health 0 Specialty intermediates 0 Formulation 0 Active Pharmaceutical Ingredient (API) 7.91 Radiopharmaceuticals 46.89 Contract Research and Development Services 7.87 Anti-allergic 9.75 Contract Manufacturing 17.66 Solid dosage formulations 8.71 API(Domestic & Exports) 0 Active Pharmaceutical Ingredient (API) 0 Formulations 0 Nutritional products 0 India branded pharmaceuticals 0.7 Life science chemicals 0 Others 0.51	Product Wise Break-Up Crop Protection 2.8 Specialty intermediates 0 Formulations 83.0 Active pharmaceutical ingredients 0 Radiopharmaceuticals 0 0 Allergy therapy products 0 0 Solid dosage formulations 0 Active Pharmaceutical Ingredient (API) 7.8 Active Pharmaceutical Ingredient (API) 0 Formulations 0 Nutritional products 0 India Branded pharmaceuticals 0 Life science chemicals 0 Others 6.4
Product Wise Break-Up	Product Wise Break-Up Formulations 81.22 Active Pharmaceutical Ingredient (API) 18.78 0 Radiopharmaceuticals 0 Allergy therapy products 0 Active pharmaceutical ingredients 0 India Branded pharmaceuticals 0 Nutritional products 0 Specialty intermediates 0 Life science chemicals 0 0 Solid dosage formulations 0 Crop Health 0 API(Domestic & Exports) 0 Formulation 0	Product Wise Break-Up Crop Health 0 Specialty intermediates 0 Formulation 0 Active Pharmaceutical Ingredient (API) 7.91 Radiopharmaceuticals 46.89 Contract Research and Development Services 7.87 Anti-allergic 9.75 Contract Manufacturing 17.66 Solid dosage formulations 8.71 API(Domestic & Exports) 0 Active Pharmaceutical Ingredient (API) 0 Formulations 0 Nutritional products 0 India branded pharmaceuticals 0.7 Life science chemicals 0 Others 0.51	Product Wise Break-Up Crop Protection 2.8 Specialty intermediates 0 Formulations 83.0 Active pharmaceutical ingredients 0 Radiopharmaceuticals 0 0 Allergy therapy products 0 0 Solid dosage formulations 0 Active Pharmaceutical Ingredient (API) 7.8 Active Pharmaceutical Ingredient (API) 0 Formulations 0 Nutritional products 0 India Branded pharmaceuticals 0 Life science chemicals 0 Others 6.4
Location Wise Break-Up	Location Wise Break-Up Rest of the World 60.76 India 39.24 China 0 Americas and Europe 0 USA 0	Location Wise Break-Up Americas and Europe 91.35 USA 0 Rest of the World 5.89 China 0 India 2.76	Location Wise Break-Up Americas and Europe 0 USA 71.37 Rest of the World 16.18 China 0 India 12.44 Others 0.01
Therapeutic Area Break-Up	Therapeutic Area Break-Up Others 100	-	-

Alembic Pharmaceuticals Ltd.

Alembic Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE